Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $29.9 Million - $39.5 Million
-350,827 Reduced 49.4%
359,405 $38.9 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $21.6 Million - $33.9 Million
-365,042 Reduced 33.95%
710,232 $65 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $5.3 Million - $8.84 Million
-141,055 Reduced 11.6%
1,075,274 $67.4 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $334,917 - $482,466
7,717 Added 0.64%
1,216,329 $53.8 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $6.14 Million - $7.19 Million
130,317 Added 12.09%
1,208,612 $58.8 Million
Q1 2023

May 15, 2023

SELL
$36.57 - $58.29 $14.6 Million - $23.3 Million
-400,442 Reduced 27.08%
1,078,295 $59.9 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $3.07 Million - $4.3 Million
89,817 Added 6.47%
1,478,737 $59.4 Million
Q3 2022

Nov 14, 2022

SELL
$36.93 - $56.68 $58.9 Million - $90.4 Million
-1,594,234 Reduced 53.44%
1,388,920 $60.9 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $12.3 Million - $19.5 Million
438,000 Added 17.21%
2,983,154 $106 Million
Q1 2022

May 16, 2022

BUY
$30.32 - $91.33 $39 Million - $118 Million
1,286,846 Added 102.27%
2,545,154 $104 Million
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $10.6 Million - $14.6 Million
122,987 Added 10.83%
1,258,308 $118 Million
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $11.1 Million - $14.1 Million
-111,307 Reduced 8.93%
1,135,321 $127 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $26.8 Million - $37.3 Million
311,927 Added 33.37%
1,246,628 $142 Million
Q1 2021

May 17, 2021

BUY
$91.47 - $124.36 $33.6 Million - $45.7 Million
367,596 Added 64.82%
934,701 $94.9 Million
Q4 2020

Feb 16, 2021

SELL
$66.66 - $111.74 $1.21 Million - $2.03 Million
-18,187 Reduced 3.11%
567,105 $56.4 Million
Q3 2020

Nov 16, 2020

BUY
$45.89 - $72.67 $1.47 Million - $2.33 Million
32,020 Added 5.79%
585,292 $42.3 Million
Q2 2020

Aug 14, 2020

SELL
$26.36 - $49.86 $3.85 Million - $7.27 Million
-145,880 Reduced 20.87%
553,272 $27.6 Million
Q1 2020

May 15, 2020

BUY
$17.27 - $40.17 $3.05 Million - $7.09 Million
176,498 Added 33.77%
699,152 $20.9 Million
Q4 2019

Feb 14, 2020

SELL
$32.1 - $40.4 $58,389 - $73,487
-1,819 Reduced 0.35%
522,654 $17.6 Million
Q3 2019

Nov 14, 2019

BUY
$25.38 - $34.89 $13.3 Million - $18.3 Million
524,473 New
524,473 $17.2 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.